ArticleFood science & nutrition2025
Jun Ginger Extract Improves Cold-Induced Asthma by Inhibiting Airway Inflammation via PI3K/AKT Pathway.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liensinine Ameliorating Oxidative Damage to Vascular Endothelium In Vitro via Upregulating eNOS and Nrf2/HO-1 Signaling.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Jun Ginger (JG), a differently processed product from conventional dried ginger (CDG), lacks research on its health benefits. The study was designed to elucidate the bioactive components and therapeutic mechanisms of JG for cold-induced asthma (CA). In the present study, after the extraction methods of different processing products were optimized, the components of the aqueous-soluble extract of JG (JGAE) were identified by LC-TOF-MS. The protection of JGAE against CA was explored using CA mice and lipopolysaccharide (LPS)-injured BEAS-2B cells. After the metabolomics analysis, network pharmacology prediction and molecular docking test were performed, the effect of JGAE in regulating the phosphatidylinositol 3'-kinase/protein kinase B (PI3K/Akt) pathway was explored and validated by the PI3K inhibitor LY294002 and activator 740Y-P. The results showed that JGAE outperformed CDG and volatile oil of JG in ameliorating CA, and gingerols were the main components. JGAE decreased the Penh value, inflammatory cells, Th2-type cytokines and MUC5AC, and increased aquaporin 1 (AQP1) and AQP5. Metabolomics analysis indicated that the acidic metabolites were restored after JGAE treatment. Network pharmacology and molecular docking results suggested that downregulating the PI3K/Akt pathway might be the key mechanism, which was validated by the PI3K inhibitor and activator. These findings indicate that JG is a potential dietary intervention for CA management by downregulating the PI3K/Akt pathway, and gingerols might be the main active component.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.